1. Home
  2. APLT

as 10-28-2025 9:36am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Founded: 2016 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 178.6M IPO Year: 2019
Target Price: $4.13 AVG Volume (30 days): 5.8M
Analyst Decision: Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.48 EPS Growth: N/A
52 Week Low/High: $0.29 - $10.62 Next Earning Date: 11-10-2025
Revenue: $121,000 Revenue Growth: -95.45%
Revenue Growth (this year): -25.28% Revenue Growth (next year): 5935.35%

Share on Social Networks: